Description

2-[(4-Bromophenoxy)Methyl]-5-[4-(4-Methoxyphenyl)Piperazin-1-Yl]-1,3-Oxazole-4-Carbonitrile is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is of significant value in medicinal chemistry research and development, serving as a critical building block for the synthesis of novel bioactive molecules. It is primarily sought after by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing new therapeutic agents, particularly within the fields of central nervous system (CNS) and oncology drug discovery.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates targeting specific biological pathways.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies to optimize potency and selectivity.
• Library Synthesis: Employed in the generation of diverse compound libraries for high-throughput screening (HTS) campaigns.
• Biochemical Probe Development: Serves as a starting material for creating tool compounds to investigate enzyme or receptor function.
• Contract Research & Manufacturing (CRAM): Supplied to organizations providing custom synthesis and process development services.
• Academic Research: Utilized in university and institutional labs for fundamental research in organic synthesis and pharmacology.

Basic Information

Product Name	2-[(4-Bromophenoxy)Methyl]-5-[4-(4-Methoxyphenyl)Piperazin-1-Yl]-1,3-Oxazole-4-Carbonitrile
CAS No.	573698-41-6
Molecular Formula	C22H21BrN4O2
Molecular Weight	453.34 g/mol
Synonyms	5-[4-(4-Methoxyphenyl)piperazin-1-yl]-2-[(4-bromophenoxy)methyl]-1,3-oxazole-4-carbonitrile; 2-((4-Bromophenoxy)methyl)-5-(4-(4-methoxyphenyl)piperazin-1-yl)oxazole-4-carbonitrile; 573698-41-6; 4-Cyano-2-[(4-bromophenoxy)methyl]-5-[4-(4-methoxyphenyl)-1-piperazinyl]oxazole; Oxazole-4-carbonitrile, 2-[(4-bromophenoxy)methyl]-5-[4-(4-methoxyphenyl)-1-piperazinyl]-
EINECS	Contact for details

Quality Control

Our production of 2-[(4-Bromophenoxy)Methyl]-5-[4-(4-Methoxyphenyl)Piperazin-1-Yl]-1,3-Oxazole-4-Carbonitrile adheres to stringent quality management protocols. Every batch undergoes comprehensive analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing all specifications are provided and can be tailored to meet specific client requirements for research or cGMP applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). This compound is light-sensitive (store away from light) and may be hygroscopic (moisture-sensitive); therefore, containers should be kept sealed under an inert atmosphere if specified for long-term storage.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.